VitaNova Life Sciences (VNOV) Return on Equity (2018 - 2026)

VitaNova Life Sciences has reported Return on Equity for 9 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Jan 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.01% in Q1 2023, with the low at 0.11% in Q1 2022.
• Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2026.
• Annual changes were most pronounced in 2022 — Return on Equity fell 11 bps — and 2023, when it grew 12 bps.
• VitaNova Life Sciences' Return on Equity stood at 0.0% in 2022, then jumped by 69 bps to 0.01% in 2023, then sank by 79 bps to 0.0% in 2024, then soared by 209 bps to 0.0% in 2025, then fell by 13 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.